Characterization of the Vaginal Microbiome in Women with Infertility and Its Potential Correlation with Hormone Stimulation during In Vitro Fertilization Surgery Original paper
-
Dr. Umar
Read MoreClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
What was studied?
This study, Characterization of the Vaginal Microbiome in Women with Infertility and Its Potential Correlation with Hormone Stimulation during In Vitro Fertilization Surgery, investigated vaginal microbiome signatures in women with secondary infertility, comparing them with healthy women and examining whether ovulation-inducing hormone stimulation during IVF alters these microbial communities. The goal was to identify microbial shifts—particularly deviations from microbiome patterns dominated by Lactobacillus—that might contribute to infertility or IVF outcomes.
Who was studied?
Researchers analyzed vaginal swabs from 30 women with secondary infertility undergoing IVF and 92 healthy women aged 23–42. Samples were collected during distinct hormonal phases: follicular and ovulatory stages for healthy women, and before and after GnRH agonist plus recombinant hCG stimulation for infertility patients. The study, therefore, captured microbial variation across natural and pharmacologically induced hormonal contexts.
Most important findings
Infertile women exhibited reduced vaginal microbiome diversity and richness, especially during the follicular phase. Their communities showed lower Lactobacillus and Leuconostoc abundance, paired with higher levels of Atopobium, Aerococcus, and Bifidobacterium. LEfSe analysis identified 17 taxa discriminating between infertile from healthy women, including Megasphaera, Pseudomonas, and Veillonella. These shifts moved the vaginal ecosystem toward anaerobic, BV-associated microbiota. Healthy women displayed pronounced microbial fluctuations during ovulation, including increased Cyanobacteria, Bifidobacterium, and Prevotella. Importantly, infertile women did not exhibit significant microbiome changes after hormonal stimulation during IVF, suggesting hormone-insensitive microbial communities. Correlation analyses showed strong positive associations among BV-linked anaerobes and negative associations between Firmicutes (largely Lactobacillus) and Bifidobacterium/Bacteroidetes.
Key implications
A pattern emerges in which secondary infertility aligns with a Lactobacillus-depleted, anaerobe-enriched vaginal microbiome, resembling BV-like signatures. Such communities may impair mucosal immunity, increase pH, and favor pathogen overgrowth, compromising embryo implantation potential. The lack of microbiome responsiveness to ovulation-inducing hormones suggests a dysbiotic community that is less adaptable to hormonal modulation, potentially underlying reduced reproductive success. This study highlights microbial biomarkers—Atopobium, Prevotella, Megasphaera, Aerococcus, and Bifidobacterium—that may be clinically relevant for diagnostic microbiome profiling and microbiome-targeted fertility interventions.
Citation
Zhao C, Wei Z, Yang J, Zhang J, Yu C, Yang A, Zhang M, Zhang L, Wang Y, Mu X, Heng X, Yang H, Gai Z, Wang X, Zhang L. Characterization of the vaginal microbiome in women with infertility and its potential correlation with hormone stimulation during in vitro fertilization surgery. mSystems. 2020;5(4):e00450-20. doi:10.1128/mSystems.00450-20
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.